Physician profile
Glenn D Goldstein
NPI 1164460994
$1,965.39
in general payments reported to CMS, 2019-2025
11 companies · $80.80 in 2025
The $80.80 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $203 · 2021: $170 · 2022: $508 · 2023: $246 · 2024: $87.50 · 2025: $80.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $196 · Food and Beverage: $193 · Travel and Lodging: $25.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $195.62 |
| Food and Beverage | $192.53 |
| Travel and Lodging | $25.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $460.15 | 2019-2021 | |
| Medline Industries LP | $437.84 | 2022 | |
| Abbvie INC. | $318.24 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $179.56 | 2019-2022 | |
| Pfizer INC. | $111.73 | 2023 | |
| Celgene Corporation | $110.77 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $106.77 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $100.31 | 2019 | |
| Galderma Laboratories, L.P. | $89.66 | 2019 | |
| Sun Pharmaceutical Industries INC. | $28.03 | 2019 | |
| Sientra, INC. | $22.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.